Workflow
众生药业: 第八届监事会第二十一次会议决议公告

Core Viewpoint - Guangdong Zhongsheng Pharmaceutical Co., Ltd. has decided to open a new special account for the management and use of raised funds due to changes in certain fundraising projects, ensuring compliance with relevant regulations and protecting shareholder interests [1][2]. Group 1 - The meeting of the 8th Supervisory Board was held on May 17, 2025, with three supervisors present, chaired by Mr. Tan Zhenyou [1]. - The Supervisory Board approved the proposal to open a special account for raised funds, aimed at standardizing the management, storage, and use of these funds [1]. - The decision was made after careful review and voting, with all three supervisors in favor, and no objections or abstentions [2]. Group 2 - The opening of the special account aligns with the regulatory requirements outlined in the "Guidelines for the Management and Use of Raised Funds by Listed Companies" and other relevant laws [1]. - The Supervisory Board confirmed that the new account does not harm the interests of shareholders, particularly minority shareholders [1].